1. Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells
    Raffaela Silvestre Ignarro et al, 2016, Mol Cell Biochem CrossRef
  2. Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4
    Matthew Scott Schrier et al, 2017, Front. Oncol. CrossRef
  3. Iron metabolism and drug resistance in cancer.
    Hasan Huseyin Kazan et al, 2017, Biometals CrossRef
  4. Cysteine, Glutathione, and Thiol Redox Balance in Astrocytes.
    Gethin J McBean, 2017, Antioxidants (Basel) CrossRef
  5. Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma
    Anahita Kyani et al, 2018, ChemMedChem CrossRef
  6. The Role of Ferroptosis in Cancer Development and Treatment Response.
    Bin Lu et al, 2017, Front Pharmacol CrossRef
  7. Novel non-apoptotic cell death: ferroptosis
    Seon Min Woo et al, 2017, Yeungnam Univ J Med CrossRef
  8. Early candidate biomarkers found from urine of glioblastoma multiforme rat before changes in MRI
    Yanying Ni et al, 2018, Sci. China Life Sci. CrossRef
  9. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis
    Bei Liu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  10. Routes to cell death in animal and plant kingdoms: from classic apoptosis to alternative ways to die—a review
    Sonia Emanuele et al, 2018, Rend. Fis. Acc. Lincei CrossRef
  11. Monitoring the Glutathione Redox Reaction in Living Human Cells by Combining Metabolic Labeling with Heteronuclear NMR
    Xing Jin et al, 2016, Angew. Chem. Int. Ed. CrossRef
  12. Monitoring the Glutathione Redox Reaction in Living Human Cells by Combining Metabolic Labeling with Heteronuclear NMR
    Xing Jin et al, 2016, Angew. Chem. CrossRef
  13. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
    Mariachiara Buccarelli et al, 2018, Cell Death Dis CrossRef
  14. Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
    Gaetano Donofrio et al, 2018, OncoImmunology CrossRef
  15. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
    Martina Da Ros et al, 2018, IJMS CrossRef
  16. Striking while the iron is hot: Iron metabolism and Ferroptosis in neurodegeneration
    Shashank Masaldan et al, 2018, Free Radical Biology and Medicine CrossRef
  17. Ferroptosis and Its Role in Diverse Brain Diseases.
    Abigail Weiland et al, 2019, Mol Neurobiol CrossRef
  18. Modulating ROS to overcome multidrug resistance in cancer
    Qingbin Cui et al, 2018, Drug Resistance Updates CrossRef
  19. Golgi stress mediates redox imbalance and ferroptosis in human cells
    Hamed Alborzinia et al, 2018, Commun Biol CrossRef
  20. Rapid Assessment of Mitochondrial Complex I Activity and Metabolic Phenotyping of Breast Cancer Cells by NAD(p)H Cytometry
    V Krishnan Ramanujan, 2018, Cytometry CrossRef
  21. Ferroptosis, a new form of cell death: opportunities and challenges in cancer.
    Yanhua Mou et al, 2019, J Hematol Oncol CrossRef
  22. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool
    Marc Dahlmanns et al, 2017, Cell Death Discovery CrossRef
  23. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Qiang Liu et al, 2019, Cell Biol Int CrossRef
  24. Population Dynamics in Cell Death: Mechanisms of Propagation
    Michelle Riegman et al, 2019, Trends in Cancer CrossRef
  25. Main path and byways: non-vesicular glutamate release by system xc−as an important modifier of glutamatergic neurotransmission
    Ann Massie et al, 2015, J. Neurochem. CrossRef
  26. Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells
    Haizhong Huo et al, 2016, PLoS ONE CrossRef
  27. Redox-based therapeutics in neurodegenerative disease
    G J McBean et al, 2017, British Journal of Pharmacology CrossRef
  28. Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells
    Arlet M. Acanda de la Rocha et al, 2016, PLoS ONE CrossRef
  29. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
    Haitao Yu et al, 2017, J. Cell. Mol. Med. CrossRef
  30. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
    Hirotaka Imai et al, 2017, Curr Top Microbiol Immunol CrossRef
  31. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
    Javier Egea et al, 2017, Redox Biology CrossRef
  32. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
    Chen Liang et al, 2019, Adv Mater CrossRef
  33. null
    Qitao Ran et al, 2019 CrossRef
  34. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
    Inês Santos et al, 2019, Nutrients CrossRef
  35. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
    Xiaojun Xia et al, 2019, Curr Gene Ther CrossRef
  36. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
    Yuki Shibata et al, 2019, PLoS One CrossRef
  37. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
    Nan Liu et al, 2020, Br J Cancer CrossRef
  38. Functional role of ferroptosis on cancers, activation and deactivation by various therapeutic candidates-an update
    B. Mahalakshmi et al, 2019, Chemico-Biological Interactions CrossRef
  39. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy
    Yunpeng Wei et al, 2020, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  40. Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
    Yongfei Yang et al, 2020, Nat Commun CrossRef
  41. Targeting Glutamine Addiction in Gliomas.
    Marta Obara-Michlewska et al, 2020, Cancers (Basel) CrossRef
  42. Ferroptosis and Its Potential Role in Human Diseases.
    Chu Han et al, 2020, Front Pharmacol CrossRef
  43. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
    Tina Sehm et al, 2016, Oncotarget CrossRef
  44. Recent progress in nanotechnology based ferroptotic therapies for clinical applications
    Yingying Xu et al, 2020, European Journal of Pharmacology CrossRef
  45. null
    Jie Yu et al, 2020 CrossRef

  46. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy


    Yuechen Zhao et al, 2020, OTT CrossRef
  47. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway
    Yan Du et al, 2020, Gene CrossRef
  48. A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
    Zhifang Hu et al, 2020, Front. Oncol. CrossRef
  49. Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
    Han-jie Liu et al, 2020, Front. Cell Dev. Biol. CrossRef
  50. Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
    Bowen Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  51. Ferroptosis in Cancer Treatment: Another Way to Rome.
    Yinan Wu et al, 2020, Front Oncol CrossRef
  52. Induction of cancer cell-specific ferroptosis by non-thermal plasma exposure
    Yasumasa Okazaki et al, 2020, Jpn. J. Appl. Phys. CrossRef
  53. miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury.
    Chenguang Ding et al, 2020, Cell Death Dis CrossRef
  54. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
    Cadiele Oliana Reichert et al, 2020, IJMS CrossRef
  55. Increased Expression of System xc− in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance
    Monika D. Polewski et al, 2016, Mol Cancer Res CrossRef
  56. Ferroptosis: mechanisms and links with diseases.
    Hong-Fa Yan et al, 2021, Signal Transduct Target Ther CrossRef
  57. Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment
    Lesang Shen et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  58. Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
    Jianyao Lou et al, 2021, Front. Oncol. CrossRef
  59. Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology
    Ekaitz Errasti-Murugarren et al, 2021, Neurochem Res CrossRef
  60. Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
    Yi Zheng et al, 2021, J Cell Mol Med CrossRef
  61. Transferrin-based radiolabeled probe predicts the sensitivity of human renal cancer cell lines to ferroptosis inducer erastin
    Yuki Shibata et al, 2021, Biochemistry and Biophysics Reports CrossRef
  62. Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation
    Sina Bader et al, 2021, Free Radical Biology and Medicine CrossRef
  63. Short overview on the relevance of microRNA–reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment
    Ozge Cemiloglu Ulker et al, 2021 CrossRef
  64. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1
    Alexander Beatty et al, 2021, Nat Commun CrossRef
  65. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo
    Qi Cheng et al, 2021, J. Obstet. Gynaecol. Res. CrossRef
  66. Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment
    Renxuan Huang et al, 2021, Cell Mol Neurobiol CrossRef
  67. Causes of drug resistance and glioblastoma relapses
    A. A. Mitrofanov et al, 2021, Opuholi golovy i šei CrossRef
  68. Recent progress on targeting ferroptosis for cancer therapy
    Guangxiang Xu et al, 2021, Biochemical Pharmacology CrossRef
  69. Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells.
    Bumin Xie et al, 2021, Cell Death Discov CrossRef
  70. Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments
    Shuang Li et al, 2021, DNA and Cell Biology CrossRef
  71. A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
    Jianglin Zheng et al, 2021, Front. Cell Dev. Biol. CrossRef
  72. From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
    Xueyuan Sun et al, 2021, Cells CrossRef
  73. A Promising Future of Ferroptosis in Tumor Therapy
    Hui Wang et al, 2021, Front. Cell Dev. Biol. CrossRef
  74. Genotoxic therapy and resistance mechanism in gliomas
    Fengchao Lang et al, 2021, Pharmacology & Therapeutics CrossRef
  75. null
    Tomas Koltai et al, 2021 CrossRef
  76. Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
    Andrés Cano-Galiano et al, 2021 CrossRef
  77. Antioxidant responses related to temozolomide resistance in glioblastoma
    José A. Campos-Sandova et al, 2021, Neurochemistry International CrossRef
  78. Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics
    Khaled S Allemailem et al, 2021, IJN CrossRef
  79. Ferroptosis, a New Insight Into Acute Lung Injury
    Xiaofang Yin et al, 2021, Front. Pharmacol. CrossRef
  80. Ferroptosis: A Trigger of Proinflammatory State Progression to Immunogenicity in Necroinflammatory Disease
    Jing-yan Li et al, 2021, Front. Immunol. CrossRef
  81. Lipoxin A4 protects primary spinal cord neurons from Erastin‐induced ferroptosis by activating the Akt / Nrf2 / HO‐1 signaling pathway
    Na Wei et al, 2021, FEBS Open Bio CrossRef
  82. iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
    Miquel Ensenyat-Mendez et al, 2021, BioData Mining CrossRef
  83. Biomimetic Gold Nanocages for Overcoming Chemoresistance of Osteosarcoma by Ferroptosis and Immunogenic Cell Death
    Chong Zhang et al, 2021, Materials & Design CrossRef
  84. Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy.
    Shunqin Zhu et al, 2021, Curr Med Chem CrossRef
  85. YENİ BİR HÜCRE ÖLÜM ŞEKLİ OLARAK FERROPTOZİS
    Alper ÇELENK, 2021 CrossRef
  86. The role of ferroptosis‐related genes for overall survival prediction in breast cancer
    Li‐Yan Jin et al, 2021, J Clin Lab Anal CrossRef
  87. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
    Junsheng Zhao et al, 2021, Front. Genet. CrossRef
  88. Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti-PD-1/PD-L1 immunotherapy in lung adenocarcinoma.
    Min Zhou et al, 2021, J Clin Lab Anal CrossRef
  89. Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC
    Yifan Zhang et al, 2021, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  90. Recent Progress of Ferroptosis in Lung Diseases
    Shangjiang Yu et al, 2021, Front. Cell Dev. Biol. CrossRef
  91. Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
    Xinyu Zhang et al, 2021, Front. Chem. CrossRef
  92. Research progress on the mechanism of ferroptosis and its clinical application
    Jiarui Xia et al, 2021, Experimental Cell Research CrossRef
  93. Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)
    Katharina Koch et al, 2021, Cancers CrossRef
  94. Induction and application of ferroptosis in cancer therapy.
    Qing Nie et al, 2022, Cancer Cell Int CrossRef
  95. Emerging Mechanisms and Disease Implications of Ferroptosis: Potential Applications of Natural Products
    Chun Ge et al, 2022, Front. Cell Dev. Biol. CrossRef
  96. GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma
    Yan Zhou et al, 2022, Front. Oncol. CrossRef
  97. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner
    Shicheng Sun et al, 2022, Cell Death Dis CrossRef
  98. Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
    Junfeng Shi et al, 2022, Front. Cell Dev. Biol. CrossRef
  99. Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer
    Erva Ozkan et al, 2022, CMC CrossRef
  100. Ferroptosis in cancer and cancer immunotherapy.
    Lei Zhao et al, 2022, Cancer Commun (Lond) CrossRef
  101. Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
    Hsin-Chih Chen et al, 2022, Antioxidants CrossRef
  102. Ferroptosis Involvement in Glioblastoma Treatment
    Andrei-Otto Mitre et al, 2022, Medicina CrossRef
  103. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis
    Zhijie Xu et al, 2022, Front. Immunol. CrossRef
  104. Targeting ferroptosis in acute kidney injury.
    Lihua Ni et al, 2022, Cell Death Dis CrossRef
  105. The dual role of p62 in ferroptosis of glioblastoma according to p53 status
    Fanen Yuan et al, 2022, Cell Biosci CrossRef
  106. From DNMT1 degrader to ferroptosis promoter: Drug repositioning of 6-Thioguanine as a ferroptosis inducer in gastric cancer
    Jinping Zhang et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  107. BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells
    Diane Moujalled et al, 2022, Cell Death Differ CrossRef
  108. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain
    Fei-Cheng Yang et al, 2022, Lab Invest CrossRef
  109. FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis
    Zhanke He et al, 2022, Archives of Biochemistry and Biophysics CrossRef
  110. Molecular Mechanisms of Iron Mediated Programmed Cell Death and Its Roles in Eye Diseases
    Jie Zhang et al, 2022, Front. Nutr. CrossRef
  111. Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis
    Helena Kram et al, 2022, Front. Oncol. CrossRef
  112. Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
    Xudong Zhang et al, 2022, Front. Pharmacol. CrossRef
  113. Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma
    Qian Sun et al, 2022, Cell Biosci CrossRef
  114. IFNγ enhances ferroptosis by increasing JAK‑STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma
    Xinbo Yu et al, 2022, Oncol Rep CrossRef
  115. Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy.
    Jing Su et al, 2022, Antioxidants (Basel) CrossRef
  116. Polystyrene microplastics up-regulates liver glutamine and glutamate synthesis and promotes autophagy-dependent ferroptosis and apoptosis in the cerebellum through the liver-brain axis.
    Kai Yin et al, 2022, Environ Pollut CrossRef
  117. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
    Xiang-jin Zheng et al, 2022, Acta Pharmacol Sin CrossRef
  118. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma
    Liying Song et al, 2022, Front. Pharmacol. CrossRef
  119. Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses
    Cheng Zhang et al, 2022, Cancer Innovation CrossRef
  120. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
    Izadora de Souza et al, 2022, IJMS CrossRef
  121. Pharmacological targets for the induction of ferroptosis: Focus on Neuroblastoma and Glioblastoma
    Luciano Ferrada et al, 2022, Front. Oncol. CrossRef
  122. Lysine‐specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4 / NOX4 pathway in mice
    Ruikang Feng et al, 2022, J Cellular Molecular Medi CrossRef
  123. Zwitterionic polymer coated sorafenib-loaded Fe3O4 composite nanoparticles induced ferroptosis for cancer therapy
    Jingbo Lin et al, 2022, J. Mater. Chem. B CrossRef
  124. Puzzling Out Iron Complications in Cancer Drug Resistance
    Marjan Abedi et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
  125. Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
    Yonghao Sun et al, 2022, Front. Oncol. CrossRef
  126. Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
    Shenghua Zhuo et al, 2022, Front. Mol. Biosci. CrossRef
  127. Self-recovery study of fluoride-induced ferroptosis in the liver of zebrafish (Danio rerio)
    Yijie Wu et al, 2022, Aquatic Toxicology CrossRef
  128. Emerging roles of ferroptosis in glioma
    Jiaqi Shi et al, 2022, Front. Oncol. CrossRef
  129. The molecular mechanisms of ferroptosis and its role in glioma progression and treatment
    Mengyang Lu et al, 2022, Front. Oncol. CrossRef
  130. Cancer suppression by ferroptosis and its role in digestive system tumors
    Jia-Jia Li et al, 2022, WCJD CrossRef
  131. Bioinformatic analysis of the LCN2-SLC22A17-MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment.
    Saverio Candido et al, 2022, Front Cell Dev Biol CrossRef
  132. The effect of narcotics on ferroptosis-related molecular mechanisms and signalling pathways
    Xiaoqin Zeng et al, 2022, Front. Pharmacol. CrossRef
  133. Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications.
    Linzhou Yin et al, 2022, Eur J Med Chem CrossRef
  134. Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery
    Sherif Ashraf Fahmy et al, 2022, Cancers CrossRef
  135. Ferroptosis in tumor immunity and therapy.
    Chuandong Gong et al, 2022, J Cell Mol Med CrossRef
  136. Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells
    Erva Ozkan et al, 2022, Life Sciences CrossRef
  137. C-MYC Inhibited Ferroptosis and Promoted Immune Evasion in Ovarian Cancer Cells through NCOA4 Mediated Ferritin Autophagy
    Yanping Jin et al, 2022, Cells CrossRef
  138. Overcoming cancer chemotherapy resistance by the induction of ferroptosis.
    Yumin Wang et al, 2023, Drug Resist Updat CrossRef
  139. Ferroptosis: mechanisms and advances in ocular diseases
    Kexin Liu et al, 2023, Mol Cell Biochem CrossRef
  140. Review of ferroptosis in colorectal cancer: Friends or foes?
    Zheng Wu et al, 2023, World J Gastroenterol CrossRef
  141. Olea europaea Leaf Phenolics Oleuropein, Hydroxytyrosol, Tyrosol, and Rutin Induce Apoptosis and Additionally Affect Temozolomide against Glioblastoma: In Particular, Oleuropein Inhibits Spheroid Growth by Attenuating Stem-like Cell Phenotype
    Melis Ercelik et al, 2023, Life CrossRef
  142. Mechanisms and applications of ferroptosis-associated regulators in cancer therapy and drug resistance
    Xiao-ying Guan et al, 2023, Journal of Chemotherapy CrossRef
  143. Nucleotide metabolism is linked to cysteine availability during ferroptosis
    Annamarie E. Allen et al, 2023, Journal of Biological Chemistry CrossRef
  144. Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism
    Pavan S. Upadhyayula et al, 2023, Nat Commun CrossRef
  145. Comprehensive Analysis of the Expression and Clinical Significance of a Ferroptosis-Related Genome in Ovarian Serous Cystadenocarcinoma: A Study Based on TCGA Data
    Hua Yang, 2022 CrossRef
  146. Molecular mechanisms of ferroptosis and their involvement in brain diseases.
    Inês Costa et al, 2023, Pharmacol Ther CrossRef
  147. Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy
    Chen Xu et al, 2023, Journal of Controlled Release CrossRef
  148. Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?
    Sarah El Hajj et al, 2023, Molecules CrossRef
  149. Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis
    Che-Yuan Hu et al, 2023, IJMS CrossRef
  150. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma
    Jiayang Cai et al, 2023, Cell Death Dis CrossRef
  151. Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis
    Zixiao Wang et al, 2023, Asian Journal of Pharmaceutical Sciences CrossRef
  152. High Expression of Ferritinophagy-Related RRM2 Gene in Relation to Unfavorable Outcome and Immune Cells Infiltration in Hepatocellular Carcinoma
    Yinghui Song et al, 2022, SSRN Journal CrossRef
  153. Novel roles for HMGA2 isoforms in regulating oxidative stress and sensitizing to RSL3-Induced ferroptosis in prostate cancer cells
    Taaliah Campbell et al, 2023, Heliyon CrossRef
  154. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS
    Leilei Wang et al, 2023, Cell Mol Biol Lett CrossRef
  155. Enhancing Vulnerability of Afatinib using Erastin via xCT-mediated ROS/P38MAPK Signaling Feedback Loop in Gastric Cancer Cells
    Gang Wei et al, 2023, Gene CrossRef
  156. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1
    Jianglin Zheng et al, 2023, J Exp Clin Cancer Res CrossRef
  157. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment
    Sicheng Wan et al, 2023, Cell Commun Signal CrossRef
  158. Construction and Validation of a Ferroptosis-Related Prognostic Model for Endometrial Cancer
    Hao Wang et al, 2021, Front. Genet. CrossRef
  159. Free Radical and Viral Infection: A Review from the Perspective of Ferroptosis
    Jun Chen et al, 2023, Veterinary Sciences CrossRef
  160. Recent advances of ferroptosis in tumor: From biological function to clinical application
    Shunfeng Hu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  161. CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia‑induced invasion and therapeutic resistance
    Jan Lumibao et al, 2023, Int J Oncol CrossRef
  162. Targeting ferroptosis opens new avenues for the development of novel therapeutics
    Shumin Sun et al, 2023, Sig Transduct Target Ther CrossRef
  163. The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer
    Audrey Marjamaa et al, 2023, Sci Rep CrossRef
  164. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs
    Chengbin Wang et al, 2023, J Exp Clin Cancer Res CrossRef
  165. Nrf2 and Ferroptosis: A New Research Direction for Ischemic Stroke
    Xiaoman Deng et al, 2023, Cell Mol Neurobiol CrossRef
  166. Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
    Xun Chen et al, 2023, Cell Death Discov. CrossRef
  167. NeuroD4 converts glioblastoma cells into neuron-like cells through the SLC7A11-GSH-GPX4 antioxidant axis
    Hao Wang et al, 2023, Cell Death Discov. CrossRef
  168. Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds
    Giuseppe Tancredi Patanè et al, 2023, IJMS CrossRef
  169. Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells
    İlknur Sur Erdem, 2023, ACAMC CrossRef
  170. Sodium Selenite Prevents Matrine-Induced Nephrotoxicity by Suppressing Ferroptosis via the GSH-GPX4 Antioxidant System
    Xi Wang et al, 2024, Biol Trace Elem Res CrossRef
  171. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment
    Yuze Hua et al, 2024, J Exp Clin Cancer Res CrossRef
  172. Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment
    Syam Mohan et al, 2024, Heliyon CrossRef
  173. MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives
    Rajni Shaw et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  174. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation
    Xin Jin et al, 2024, Cell Death Discov. CrossRef
  175. Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis
    Mengxia Yuan et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  176. Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme
    Ke Du et al, 2024, ACS Appl. Bio Mater. CrossRef
  177. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis
    Wenpeng Cao et al, 2024, Cell Death Dis CrossRef
  178. Baicalein improves renal interstitial fibrosis by inhibiting the ferroptosis in vivo and in vitro
    Guo-qiang Liang et al, 2024, Heliyon CrossRef
  179. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies
    Namdev Dhas et al, 2024, Life Sciences CrossRef
  180. HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting ferroptosis
    Weiwei Liu et al, 2024, Cell Death Discov. CrossRef
  181. Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets
    Fatemeh Nejadi Orang et al, 2024, Cell Death Dis CrossRef
  182. Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics
    Shuang Chen et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  183. Inducing ferroptosis via nanomaterials: a novel and effective route in cancer therapy
    Mine Ensoy et al, 2024, J. Phys. Mater. CrossRef
  184. Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
    YiLin Luo et al, 2024, DDDT CrossRef
  185. Ulipristal-temozolomide-hydroxyurea combination for glioblastoma: in-vitro studies
    Meric A. ALTINOZ et al, 2024, J Neurosurg Sci CrossRef
  186. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
    Yu Cao et al, 2024, Front. Immunol. CrossRef
  187. Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases
    Liuting Zeng et al, 2024, Cell Death Dis CrossRef
  188. S-allyl-cysteine triggers cytotoxic events in rat glioblastoma RG2 and C6 cells and improves the effect of temozolomide through the regulation of oxidative responses
    Carolina Y. Reyes-Soto et al, 2024, Discov Onc CrossRef
  189. Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells
    Wei Huang et al, 2024, European Journal of Medicinal Chemistry CrossRef
  190. Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance
    Maierdan Mansuer et al, 2024, Cell Death Dis CrossRef
  191. Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma
    Luyang Wang et al, 2024, J Nanobiotechnol CrossRef
  192. Ferroptosis in radiation-induced brain injury: roles and clinical implications
    Lifang Li et al, 2024, BioMed Eng OnLine CrossRef
  193. Ferroptosis: Iron-mediated cell death linked to disease pathogenesis
    Xiangyu Zhang et al, 2024, J Biomed Res CrossRef
  194. Programmed cell death and melatonin: A comprehensive review
    Mahdi Rafiyian et al, 2024, Funct Integr Genomics CrossRef
  195. PSF-lncRNA interaction as a target for novel targeted anticancer therapies
    Ren Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  196. The mutant isocitrate dehydrogenase 1 product, 2‑hydroxyglutarate, activates MutT homolog 1 in glioma cells via the augmentation of reactive oxygen species levels
    Bharathan Bhavya et al, 2022, World Acad Sci J CrossRef
  197. Novel strategies to overcome chemoresistance in human glioblastoma
    Qing Tang et al, 2024, Biochemical Pharmacology CrossRef
  198. Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies
    Wei Li et al, 2024, Front. Immunol. CrossRef
  199. Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer
    Alyaa Dawoud et al, 2024, Redox Report CrossRef
  200. Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer
    Cuixin Peng et al, 2024, Front. Oncol. CrossRef
  201. Regulation and therapy: the role of ferroptosis in DLBCL
    Yifan Wang et al, 2025, Front. Pharmacol. CrossRef
  202. Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
    Peng Zhao et al, 2025, Mol Cancer CrossRef